215 related articles for article (PubMed ID: 20461049)
1. Update on antifungal therapy with terbinafine.
Gianni C
G Ital Dermatol Venereol; 2010 Jun; 145(3):415-24. PubMed ID: 20461049
[TBL] [Abstract][Full Text] [Related]
2. Terbinafine. An update of its use in superficial mycoses.
McClellan KJ; Wiseman LR; Markham A
Drugs; 1999 Jul; 58(1):179-202. PubMed ID: 10439936
[TBL] [Abstract][Full Text] [Related]
3. Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedis.
Schäfer-Korting M; Schoellmann C; Korting HC
Skin Pharmacol Physiol; 2008; 21(4):203-10. PubMed ID: 18509254
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
[TBL] [Abstract][Full Text] [Related]
5. Stratum corneum pharmacokinetics of the anti-fungal drug, terbinafine, in a novel topical formulation, for single-dose application in dermatophytoses.
Kienzler JL; Queille-Roussel C; Mugglestone C; Ortonne JP; Larnier C
Curr Med Res Opin; 2007 Jun; 23(6):1293-302. PubMed ID: 17559730
[TBL] [Abstract][Full Text] [Related]
6. Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients.
Millikan LE
Cutis; 2001 Jul; 68(1 Suppl):6-14. PubMed ID: 11499333
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of antifungal agents in onychomycoses.
Debruyne D; Coquerel A
Clin Pharmacokinet; 2001; 40(6):441-72. PubMed ID: 11475469
[TBL] [Abstract][Full Text] [Related]
8. Itraconazole and terbinafine in perspective. From petri dish to patient.
De Doncker P; Gupta AK
Postgrad Med; 1999 Jul; Spec No():6-11. PubMed ID: 10492660
[TBL] [Abstract][Full Text] [Related]
9. The use of systemic antimycotics in dermatotherapy.
Niewerth M; Korting HC
Eur J Dermatol; 2000 Mar; 10(2):155-60. PubMed ID: 10694319
[TBL] [Abstract][Full Text] [Related]
10. Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses.
Balfour JA; Faulds D
Drugs; 1992 Feb; 43(2):259-84. PubMed ID: 1372222
[TBL] [Abstract][Full Text] [Related]
11. Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections.
Davis R; Balfour JA
Pharmacoeconomics; 1995 Sep; 8(3):253-69. PubMed ID: 10155621
[TBL] [Abstract][Full Text] [Related]
12. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
Gupta AK; Konnikov N; Lynde CW
J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
[TBL] [Abstract][Full Text] [Related]
13. [Terbinafine (Lamisil)].
Breton MC
Union Med Can; 1995 Nov; 124(3):20-5. PubMed ID: 8560634
[No Abstract] [Full Text] [Related]
14. The significance of itraconazole for treatment of fungal infections of skin, nails and mucous membranes.
Korting HC; Schöllmann C
J Dtsch Dermatol Ges; 2009 Jan; 7(1):11-9, 11-20. PubMed ID: 18479501
[TBL] [Abstract][Full Text] [Related]
15. Terbinafine: an oral and topical antifungal agent.
Shear NH; Villars VV; Marsolais C
Clin Dermatol; 1991; 9(4):487-95. PubMed ID: 1840406
[No Abstract] [Full Text] [Related]
16. The safety and efficacy of terbinafine in patients with diabetes and patients who are HIV positive.
Elewski B; Smith S
Cutis; 2001 Jul; 68(1 Suppl):23-9. PubMed ID: 11499331
[TBL] [Abstract][Full Text] [Related]
17. Treatment of cutaneous sporotrichosis with terbinafine.
Hull PR; Vismer HF
Br J Dermatol; 1992 Feb; 126 Suppl 39():51-5. PubMed ID: 1543674
[TBL] [Abstract][Full Text] [Related]
18. Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat.
Faergemann J; Zehender H; Jones T; Maibach I
Acta Derm Venereol; 1991; 71(4):322-6. PubMed ID: 1681649
[TBL] [Abstract][Full Text] [Related]
19. Special features of the clinical use of oral terbinafine in the treatment of fungal diseases.
Villars VV; Jones TC
Br J Dermatol; 1992 Feb; 126 Suppl 39():61-9. PubMed ID: 1543676
[TBL] [Abstract][Full Text] [Related]
20. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks.
Faergemann J; Zehender H; Denouël J; Millerioux L
Acta Derm Venereol; 1993 Aug; 73(4):305-9. PubMed ID: 7904107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
